Abera Bioscience AB (NGM:ABERA)
8.86
+0.04 (0.45%)
At close: Jul 24, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 181.62 million as of July 24, 2026. Its market cap has increased by 63.17% in one year.
Market Cap
181.62M
Enterprise Value
155.58M
Revenue
11.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.86
ChartMarket Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 181.62M, an increase of 57.13%. That is a compound annual growth rate of 8.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 181.62M | 44.79% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nodebis Applications AB | 212.25M |
| Fable Media Group AB | 203.82M |
| Invoicery Group AB | 203.32M |
| Xer Tech Holding AB | 195.70M |
| Spotlight Group AB | 193.28M |
| Link Prop Investment AB | 189.63M |
| Triona AB | 189.26M |
| Eurobattery Minerals AB | 187.44M |